Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

<i>Mertk</i>^<i>-/-</i> macrophages exhibit unpolarized distribution of filamentous actin and myosin II, and decreased FAK phosphorylation. by Yong Tang (161879)

“…Scale bars in (A) and (B), 5 μm. (C) Western blotting shows decreased FAK phosphorylation at tyrosine 397 after addition of apoptotic T cells for the indicated time points. …”

Image_5_Evidence for a protective effect of the loss of α4-containing nicotinic acetylcholine receptors on Aβ-related neuropathology in Tg2576 mice.jpg by Antonietta Vilella (6860801)

The <i>Listeria</i> Small RNA Rli27 Regulates a Cell Wall Protein inside Eukaryotic Cells by Targeting a Long 5′-UTR Variant by Juan J. Quereda (651911)

“…The 234-nucleotide 5′-UTR is also the target of a small RNA (sRNA) denoted Rli27, which we identified by bioinformatics analysis as having extensive base pairing potential with the long 5′-UTR. …”

A BMP7 Variant Inhibits Tumor Angiogenesis <i>In Vitro</i> and <i>In Vivo</i> through Direct Modulation of Endothelial Cell Biology by Courtney M. Tate (555115)

“…Importantly, in an <i>in vivo</i> angiogenic plug assay that serves as a measurement of angiogenesis, BMP7v significantly decreased hemoglobin content indicating inhibition of neoangiogenesis. …”

Data_Sheet_1_miR482f and miR482c-5p from edible plant-derived foods inhibit the expression of pro-inflammatory genes in human THP-1 macrophages.docx by Ester Díez-Sainz (17485836)

“…Transfections with miR482f and miR482c-5p mimics decreased the gene expression of CLEC7A and NFAM1, and TRL6, respectively, in human THP-1 monocytes differentiated to macrophages, which had an impact on gene expression profile of inflammatory biomarkers. …”

Limiting Sox2 in endothelium decreases EndMTs and calcification in <i>Ins2</i>^{<i>Akita/+</i>} aortas. by Pierre J. Guihard (3391721)

“…<p>(a-b) Decreased expression of Sox2, stem cell and mesenchymal markers in aortas of <i>Cdh5</i>^<i>Cre</i><i>Sox2</i>^{<i>Flox/wt</i>}<i>Ins2</i>^{<i>Akita/+</i>}, as shown by real-time PCR (a) and immunoblotting (b). …”

MBL decreases <i>C. albicans</i>-stimulated NF-κB binding activity and translocation in PMA-activated THP-1 cells. by Mingyong Wang (504578)

Decreased recovery of NOD2^−/− compared to WT TCR transgenic CD8 T cells following respiratory influenza infection of mice. by Gloria H. Y. Lin (247710)

Over-expression of YKL-40 in 76N MECs decreases E-cad and β-casein, but increases MMP-9 expression and cell invasiveness. by Steve Scully (202724)

Increased retention of chemotherapeutics in MDR cells treated for extended times with P-glycoprotein inhibitor decreases cell motility as determined by wound healing assays. by Amila K. Nanayakkara (6812384)

MO-A protects against cerebral injury after MCAO in rats. by Mingbao Lin (727751)

Decreased <i>Leishmania</i> species infection and increased leishmanicidal molecules after IL-32 overexpression in human THP-1-derived macrophages. by Jéssica Cristina dos Santos (600716)

DataSheet_1_Zerumbone Modulates α2A-Adrenergic, TRPV1, and NMDA NR2B Receptors Plasticity in CCI-Induced Neuropathic Pain In Vivo and LPS-Induced SH-SY5Y Neuroblastoma In Vitro Mod... by Jasmine Siew Min Chia (8524626)

“…Zerumbone treatment markedly decreased the expression of α_2A-adrenoceptor, while an up-regulation was observed of NMDA NR2B receptors. …”